secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2022-09-02T23:59:59+00:00
Accession:  0001062822-22-000037
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon amends loan with Oxford Finance; $25M tranche drawable Dec 1-31, 2022
-----------------------------------------------------------------------------

- First Amendment to Loan and Security Agreement with Oxford Finance LLC executed Aug 29, 2022.
- Second $25M tranche draw period changed to Dec 1-31, 2022, subject to conditions and no Event of Default.
- Sotagliflozin NDA Milestone already achieved, as confirmed by Collateral Agent.
- Amendment fee and Lender Expenses payable; other loan terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282222000037/0001062822-22-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282222000037/lxrx-20220829.htm
  HTML page:      https://secwatch.observer/filing/0001062822-22-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer